Drug Week
Susan Hasty, Publisher
Table of Contents . . . January 11th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Week | Other Publications
Infectious Disease Therapy - Pediatric Oxacillin Use Carries Heightened Risk of Liver Damage
Multiple Myeloma - Osteoprotegerin Reduces Bone Degradation
AIDS and HIV Therapies - Interleukin-2 Does Not Increase Virus-Specific T-Cell Activity
Acute Myeloid Leukemia - Cyclosporine A Reduces Chemotherapy Resistance
Chronic Myeloid Leukemia - Interferon-(alpha) With Cytarabine Effective For Early Treatment
Neutraceuticals - Studies Say Creatine Is OK
Thrombosis - ADP Receptor Blockade Reduces Platelet Clumping
Alzheimer Disease - Long-Term Cognitive and Functional Improvements Shown With Memantine
Appointments - Consensus Pharmaceuticals Names New CEO
Appointments - NeoTherapeutics Appoints Former Pfizer Clinical Research Exec To NeoOncoRx Scientific Advisory Board
Appointments - West Pharmaceutical Services Hires Drug Delivery President
B-Cell Lymphoma - Experimental Cancer Drug Beta-Alethine Produces Promising Responses
Bladder Cancer - Intravesical Neoquin Shows Antitumor Activity Against Superficial Disease
Blood Cell Cancers - Arsenic Trioxide Shown Safe For A Variety Of Patients
Breast Cancer - Anastrozole More Effective Than Tamoxifen In Early Disease
Breast Cancer - Significant Survival Advantages For Combination Chemotherapy Patients
Chronic Myeloid Leukemia - Outstanding Response Rates In Imatinib Mesylate-Treated Patients
Clinical Trials - CogScreen, Invivodata Collaborate To Offer Real-Time Subjective Data Collection
Drug Development - Positive Phase I/II Clinical Results Of Novel Narcotic Announced
Erectile Dysfunction - Early Vardenafil Phase III Data Report Positive Results
Ethics - AAMC Issues New Guidelines On Financial Conflicts Of Interest
Leukemia - Phase I Results Of Tezacitabine Provide Rationale For Phase II Study
Malignant Glioma - Gliadel Wafer Provides Clinical Benefit With Acceptable Safety
Oral Mucositis - Repifermin Demonstrates Excellent Safety Profile In Phase IIa Clinical Trials
Regulatory Issues - Perrigo Gets FDA Nod On Treatments For Yeast Infections, Migraines
Reincorporation - Interallied Group Changes Name To Pilot Therapeutics Holdings
Reorganizations - West Pharmaceutical Services Consolidates Divisions
Respiratory Distress Syndrome - Discovery Laboratories And Quintiles To Commercialize Surfaxin
Sexual Dysfunction - Cellegy Issued Patent for Testosterone Gel in the United States
Type 2 Diabetes - First Phase III Pivotal Trial Of Synthetic Exendin-4 Initiated
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
